OGI

What one share of Organigram Holdings holds

Pharmaceutical Preparations

Organigram Holdings’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2025-09-30; the balance sheet is as of 2025-09-30.

Per-share figures
Sales$1.45
Profit−$0.14
Capex (buildings and equipment)$0.10
Free cash flow−$0.14
Cash and investments$0.45
Debt$0.00
Book value$1.86

Per share by fiscal year

YearSalesProfitCapexFree cashDividendsBook value
2018$0.31$0.51$1.39−$1.71—$4.51
2019$1.60−$0.21$2.17−$2.86—$6.30
2020$1.45−$2.34$1.29−$2.04—$4.73
2021$0.98−$1.61$0.14−$0.50—$5.09
2022$1.48−$0.15$0.50−$0.86—$4.95
2024$1.23−$0.35$0.04−$0.01—$2.09
2025$1.45−$0.14$0.10−$0.14—$1.86

Common questions about Organigram Holdings

How much does one share of Organigram Holdings earn?

Over its latest fiscal year, Organigram Holdings lost $0.14 for each share on $1.45 of sales.

Does Organigram Holdings pay a dividend?

Organigram Holdings didn’t pay a dividend over its latest fiscal year, according to its SEC filings.

What is Organigram Holdings’s book value per share?

Organigram Holdings’s book value is $1.86 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of September 30, 2025.

How much cash and debt does each share of Organigram Holdings have?

Each share of Organigram Holdings has $0.45 of cash and investments and $0.00 of debt, as of September 30, 2025.

What is Organigram Holdings’s free cash flow per share?

−$0.14 per share over its latest fiscal year. Free cash flow is the cash left over after spending on buildings and equipment.

Has Organigram Holdings bought back shares?

Organigram Holdings’s share count rose about 303% from 2018 to 2025. That dilution means each share owns a smaller slice of the company.

From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.